Company Description
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them.
The company’s marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types.
It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions.
iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
| Country | United States |
| Founded | 2009 |
| IPO Date | Jun 17, 2021 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Katharyn Field |
Contact Details
Address: 8 Cabot Road, Suite 1800 Woburn, Massachusetts 01801 United States | |
| Phone | 781 301 6700 |
| Website | ispecimen.com |
Stock Details
| Ticker Symbol | ISPC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 1558569 |
| CUSIP Number | 45032V306 |
| ISIN Number | US45032V3069 |
| Employer ID | 27-0480143 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Chief Executive Officer, President, Secretary and Treasurer |
| Yuying Liang | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2026 | D | Notice of Exempt Offering of Securities |
| May 13, 2026 | 8-K | Current Report |
| May 1, 2026 | 8-K | Current Report |
| Apr 13, 2026 | 8-K | Current Report |
| Apr 10, 2026 | 8-K | Current Report |
| Apr 1, 2026 | 10-K | Annual Report |
| Mar 31, 2026 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 13, 2026 | 8-K | Current Report |
| Mar 3, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 23, 2026 | 8-K | Current Report |